Key points are not available for this paper at this time.
Abstract A number of biologically relevant O 4 ‐phospho‐L‐tyrosine‐containing peptides have been synthesized by either the global phosphorylation of the side‐chain‐unprotected L‐tyrosine moiety in presynthesized resin‐bound peptides or alternatively by the incorporation of suitably protected O 4 ‐phospho‐L‐tyrosine building blocks in the continuous‐flow method of Fmoc solid‐phase peptide synthesis. Different phosphate‐protecting groups have been applied.
Kitas et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: